Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: A 12-month real-life experience

Purpose: To compare the functional and anatomical outcomes of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema (DME) in real-life conditions. Methods: In this retrospective cohort study, data were obtained from the hospital database...

Full description

Bibliographic Details
Published in:	Indian Journal of Ophthalmology
Main Authors:	Osman Parca, Ebru N Cetin
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-03-01
Subjects:	aflibercept dexamethasone diabetic macular edema ranibizumab real-life study
Online Access:	https://journals.lww.com/10.4103/IJO.IJO_2310_23

Similar Items

Ranibizumab or Aflibercept Monotherapies in Treatment-Naive Eyes with Diabetic Macular Edema: A Head-to-Head Comparison in Real-Life Experience
by: Mahmut Kaya, et al.
Published: (2023-02-01)

Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
by: Hakan Koc, et al.
Published: (2023-03-01)

Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes – 1-year outcomes from a quazi-randomized study in India
by: Debdulal Chakraborty, et al.
Published: (2024-04-01)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016-08-01)

Macular Ischemia Changes in Patients with Diabetic Macular Edema Treated with Aflibercept and Ranibizumab
by: Dimitrios Maris, et al.
Published: (2024-06-01)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
by: Hiromi Ohara, et al.
Published: (2023-06-01)

Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2024-11-01)

Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
by: Hsin-Ho Chang, et al.
Published: (2024-10-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Aflibercept monotherapy or bevacizumab first for diabetic macular edema
by: Avner Hostovsky, et al.
Published: (2024-01-01)

RANIBIZUMAB MONOTHERAPY VERSUS COMBINED RANIBIZUMAB PLUS TRIAMCINOLONE FOR TREATING DIABETIC MACULAR EDEMA; EVALUATION AFTER SINGLE INJECTION
by: Fareed A AL-Laftah
Published: (2015-12-01)

Comparison of Efficacy of Intravitreal Dexamethasone Implant versus Ranibizumab Biosimilar for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Shashank Narang, et al.
Published: (2025-07-01)

Intravitreal Aflibercept Therapy in Intravitreal Bevacizumab/Ranibizumab Treatment-resistant Exudative Age-related Macular Degeneration
by: Neslihan Sevimli, et al.
Published: (2023-09-01)

Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis
by: Khaled Moghib, et al.
Published: (2025-04-01)

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
by: Serhad Nalçacı, et al.
Published: (2019-04-01)

Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema: a retrospective cohort study
by: Leonardo Mastropasqua, et al.
Published: (2019-10-01)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01)

Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study
by: Yule Xu, et al.
Published: (2017-08-01)

Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01)

Comparative Efficacy of Intravitreal Aflibercept and Dexamethasone Implant in Treating Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion: A Meta-Analysis and Systematic Review
by: Khaled Moghib, et al.
Published: (2025-01-01)

Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis
by: Xian Wang, et al.
Published: (2022-06-01)

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab
by: Flora Elwes, et al.
Published: (2018-01-01)

Evaluation of topical bromfenac as an adjunctive treatment with intravitreal ranibizumab in the management of diabetic macular edema
by: Sara S. Emara, et al.
Published: (2024-10-01)

Comparison of intravitreal aflibercept and dexamethasone implant in the treatment of macular edema associated with diabetic retinopathy or retinal vein occlusion: a Meta-analysis and systematic review
by: Xuan-Yu Qiu, et al.
Published: (2022-09-01)

Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
by: Ayşe Ergin, et al.
Published: (2022-12-01)

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
by: Alsaedi NG, et al.
Published: (2021-07-01)

Effectiveness of intravitreal ranibizumab for diabetic macular edema in vitrectomized versus non-vitrectomized eyes: a Meta-analysis
by: Yi-Heng Wang, et al.
Published: (2024-04-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Intravitreal aflibercept for diabetic macular edema: structural and functional improvements
by: Chuanhe Zhang, et al.
Published: (2025-02-01)

One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders
by: Ali Salimi, et al.
Published: (2021-01-01)

Changes of hard exudates in response to intravitreal injection of ranibizumab and lipid lowering medications in diabetic macular edema
by: Aya M.A. Ghonaim, et al.
Published: (2025-07-01)

Evaluation of diabetic macular edema by using optical coherence tomography in patients underwent combined phacoemulsification and intravitreal ranibizumab injection versus patients underwent sequential intravitreal ranibizumab injection and phacoemulsification: an observational study
by: Mohamed T El-Behaidy, et al.
Published: (2023-01-01)

Two Year Study of Aflibercept and Ranibizumab Intravitreal Therapy in Patients with Wet AMD
by: Dorota Luksa, et al.
Published: (2021-11-01)

Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
by: Ayumi Usui-Ouchi, et al.
Published: (2021-01-01)

Efficacy of Intravitreal Dexamethasone Implant (Ozurdex<sup>®</sup>) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema
by: Panagiotis Stavrakas, et al.
Published: (2025-03-01)

Comparison of three loading doses of bevacizumab and ranibizumab for macular edema due to branch retinal vein occlusion
by: Sibel Coşkun Akdemir, et al.
Published: (2025-05-01)

Effect of dexamethasone implant on intraocular cytokines in diabetic macular edema
by: Gopal S Pillai, et al.
Published: (2023-01-01)

Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis
by: Rishi B. Gupta, et al.
Published: (2023-09-01)

Functional improvements of diabetic macular edema after treatment with Ranibizumab
by: Hussam O Elrashidy
Published: (2021-01-01)

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema
by: Yao Shen, et al.
Published: (2025-08-01)